Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2023 Earnings Call Transcript

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2023 Earnings Call Transcript May 15, 2023

Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.41, expectations were $-0.46.

Operator: Good morning and welcome to the Fulcrum Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode. This call is being webcast live on the Investor Section of Fulcrum’s website at www.fulcrumtx.com and is being...